Anne Hume to Risk Assessment
This is a "connection" page, showing publications Anne Hume has written about Risk Assessment.
Connection Strength
0.138
-
Jackson AN, Hume AL. Aspirin for CV prevention -- for which patients? J Fam Pract. 2011 Sep; 60(9):518-23.
Score: 0.055
-
Burkiewicz JS, Vesta KS, Hume AL. Improving effectiveness in communicating risk to patients. Consult Pharm. 2008 Jan; 23(1):37-43.
Score: 0.043
-
Eaton CB, Lapane KL, Murphy JB, Hume AL. Effect of statin (HMG-Co-A-Reductase Inhibitor) use on 1-year mortality and hospitalization rates in older patients with cardiovascular disease living in nursing homes. J Am Geriatr Soc. 2002 Aug; 50(8):1389-95.
Score: 0.029
-
Christian JB, Lapane KL, Hume AL, Eaton CB, Weinstock MA. Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial. J Natl Cancer Inst. 2008 Sep 03; 100(17):1223-32.
Score: 0.011